DelveInsight Business Research LLP

DelveInsight’s “Bowel Obstruction Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Bowel Obstruction, historical and forecasted epidemiology as well as the Bowel Obstruction market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Key Highlights for Bowel Obstruction Market 

• Key companies working in Anti the hypertension market include Ipsen, Pacira Pharmaceuticals, Marathon Pharmaceuticals, VectivBio AG, Zealand Pharma, Arena Pharmaceuticals, and many others.

• Key therapies in the Bowel Obstruction  market include Omnipaque,  Lanreotide,  Loperamide, and many others 

• The Market Size for Bowel Obstruction market is expected to be USD XX Million by 2032.

• The CAGR for Bowel Obstruction  market is expected to be XX% 

Bowel Obstruction Overview 

A bowel obstruction can either be a mechanical or functional obstruction of the small or large intestines. The obstruction occurs when the lumen of the bowel becomes either partially or completely blocked. Obstruction frequently causes abdominal pain, nausea, vomiting, constipation-to-obstipation, and distension. This, in turn, prevents the normal movement of digested products. Small bowel obstructions are more common than large bowel obstructions and are the most frequent indication for surgery on the small intestines. Bowel obstructions are classified as a partial, complete, or closed loop. A closed-loop obstruction refers to a type of obstruction in the small or large bowel in which there is complete obstruction distally and proximally in the given segment of the intestine

Bowel Obstruction Epidemiological Facts 

• The incidence of bowel obstruction increases with age; the median age at diagnosis is 64 years. The incidence of bowel obstruction in newborns is 1 in 2000 live births. The incidence of bowel obstruction in children after the first 2 years of life is 1 in 5000.

• The incidence of bowel obstruction is 1.47 per 100,000 per year in the United States.

• The incidence of large bowel obstruction is approximately 0.15 – 0.29 per 100,000 in patients with colorectal cancer.

• It should be noted that 770 per 100,000 of surgical emergencies with colorectal carcinoma are attributed to bowel obstruction.

• The incidence of bowel obstruction in cases of Crohn’s disease may be as high as 250 per 100,000.

Click here to learn more about the Bowel Obstruction Market Landscape

The Report Covers the Bowel Obstruction Epidemiology Segmented by:

• Bowel Obstruction prevalent case 

• Bowel Obstruction incident cases 

• Bowel Obstruction cases based on age 

• Bowel Obstruction cases based on fatality/mortality rate 

Bowel Obstruction Market Outlook

The Bowel Obstruction market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Bowel Obstruction market trends by analyzing the impact of current Bowel Obstruction therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Bowel Obstruction market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Bowel Obstruction market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Bowel Obstruction market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Bowel Obstruction Market

• Marathon Pharmaceuticals

• VectivBio AG

• Zealand Pharma

• Arena Pharmaceuticals

• Ipsen

• Pacira Pharmaceuticals

And many others 

Bowel Obstruction Therapies Covered and Analyzed in the Report

• Omnipaque

• Lanreotide

• Loperamide

And many others 

Learn more about the Key Companies and Emerging Therapies in the Bowel Obstruction Market

Table of Contents 

1. Key Insights 

2. Bowel Obstruction Introduction 

3. Executive Summary of Bowel Obstruction     –     

4. Disease Background and Overview

5. Epidemiology and patient population

6. Bowel Obstruction Emerging Therapies

7. Bowel Obstruction Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ Bowel Obstruction Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services